Observation Versus Embolization in Patients with Blunt Splenic Injury after Trauma: A Propensity Score Analysis by Olthof, D.C. et al.
ORIGINAL SCIENTIFIC REPORT
Observation Versus Embolization in Patients with Blunt Splenic
Injury After Trauma: A Propensity Score Analysis
Dominique C. Olthof1 • Pieter Joosse2 • Patrick M.M. Bossuyt3 • Philippe P. de Rooij4 •
Loek P. H. Leenen5 • Klaus W. Wendt6 • Frank W. Bloemers7 • J. Carel Goslings1
Published online: 30 December 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Background Non-operative management (NOM) is the standard of care in hemodynamically stable patients with
blunt splenic injury after trauma. Splenic artery embolization (SAE) is reported to increase observation success rate.
Studies demonstrating improved splenic salvage rates with SAE primarily compared SAE with historical controls.
The aim of this study was to investigate whether SAE improves success rate compared to observation alone in
contemporaneous patients with blunt splenic injury.
Methods We included adult patients with blunt splenic injury admitted to five Level 1 Trauma Centers between
January 2009 and December 2012 and selected for NOM. Successful treatment was defined as splenic salvage and no
splenic re-intervention. We calculated propensity scores, expressing the probability of undergoing SAE, using
multivariable logistic regression and created five strata based on the quintiles of the propensity score distribution. A
weighted relative risk (RR) was calculated across strata to express the chances of success with SAE.
Results Two hundred and six patients were included in the study. Treatment was successful in 180 patients: 134/146
(92 %) patients treated with observation and 48/57 (84 %) patients treated with SAE. The weighted RR for success
with SAE was 1.17 (0.94–1.45); for complications, the weighted RR was 0.71 (0.41–1.22). The mean number of
transfused blood products was 4.4 (SD 9.9) in the observation group versus 9.1 (SD 17.2) in the SAE group.
Conclusions After correction for confounders with propensity score stratification technique, there was no signifi-
cant difference between embolization and observation alone with regard to successful treatment in patients with blunt
splenic injury after trauma.
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Introduction
Trauma is a leading cause of mortality globally, especially
among people below the age of 40 years [1, 2]. One of the
organs frequently injured after blunt abdominal trauma is the
spleen [3]. In the past, splenic injuries were treated with
laparotomy and splenectomy. Nowadays, in hemodynamically
(HD) stable patients without other indications for laparotomy,
non-operative management (NOM) is the standard of care.
NOM includes close observation of the patient and can be
supplemented with splenic artery embolization (SAE).
SAE is generally reported to increase the success rate of
NOM, approaching 98 % [4–10]. However, according to
Harbrecht et al., those studies that demonstrated improved
splenic salvage rates with SAE primarily compared SAE
with historical NOM controls, as opposed to using con-
temporaneous controls or randomized controlled study
designs [11]. In a second paper, looking at NOM in general
(observation supplemented with SAE, if necessary), Har-
brecht et al. showed that the improvement in the success
rate of NOM of patients with blunt splenic injuries over
time is caused, in part, by the increase in detection of
relatively minor splenic injuries [12]. Thus, although SAE
appears a promising strategy for improving successful
treatment rates, its role should be further investigated,
preferably in a well-designed prospective (randomized)
controlled trial comparing it to strictly observational
management.
Such a trial, comparing observation to SAE, would
require a large sample size (approximately 940 patients to
detect 5 % difference in failure rate (i.e., the need for
surgery)). Furthermore, it would be considered unethical to
withhold SAE from a patient with, for example, a high-
grade splenic injury or a contrast extravasation. However,
previous research has shown that there is a need for such a
randomized controlled trial [13]. Requarth et al. have
addressed this issue in a meta-analysis [14]. The authors
showed that SAE was associated with significantly lower
failure rates in the higher grade splenic injuries (AAST
grades 4 and 5). The available data did not enable the
authors to look at contrast extravasation or the presence of
pseudoaneurysm on CT and its relationship to the value of
SAE, which is essential as the presence of these findings is
a (possible) indication for SAE.
As an alternative, propensity scoring matching (PSM)
analysis can be applied, a methodology that is used to
control for treatment selection bias and to simulate, as
closely as possible, the randomization process [15]. Using
PSM analysis, we set out to investigate whether SAE
improves success rate compared to observation alone in
patients with blunt splenic injury.
Materials and methods
Study design
A retrospective, multicenter, cohort study was performed
using the local Trauma Registries, a prospective, compre-
hensive registration of all acutely (within 24 h) admitted
trauma patients. Five Level 1 Dutch trauma centers par-
ticipated in the study. Data were collected from January
2009 to December 2012. All adult patients (age C 16 -
years) with blunt splenic injury (Abbreviated Injury Scale
codes 544299.2, 544210.2 through to 544228.5 and
544240.3, AIS manual Update 98 [16]) who were initially
treated non-operatively were included. Initial treatment
strategy was defined as the first selected treatment strategy
following admission. Patients who were treated opera-
tively, patients who died in the emergency department, and
patients transferred from another hospital (unless findings
of initial assessment were adequately documented) were
excluded.
The Medical Research Involving Human Subjects Act
(in Dutch: WMO) exempts this type of research from
informed consent. The ethics committees of all five hos-
pitals confirmed that official approval was not required.
Outcome measures
The primary endpoint, successful treatment, was defined as
the combination of splenic salvage without the need for a
(re-)intervention. Treatment was considered unsuccessful if
a splenectomy or another type of re-intervention was per-
formed. Re-interventions included SAE or splenic surgery
for patients who were initially selected for observation, and
re-SAE or splenic surgery for patients who were initially
embolized. Only re-interventions occurring within 30 days
after discharge were taken into consideration. Secondary
endpoints were (all-cause) complications and transfused
blood products (defined as the total number of transfused
packed cells, fresh frozen plasma, and thrombocytes during
index admission). A complication was defined as any
medical procedure performed for an undesirable event
(whether spleen-related or not) during index admission
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(e.g., additional imaging, medication (e.g., antibiotics),
drop in hemoglobin requiring transfusion).
Data collection
Data collection was performed on location by one
researcher (DO). The following data were collected: age,
gender, Injury Severity Score (ISS), total length of hospital
stay and length of stay in the Intensive Care Unit, systolic
blood pressure (SBP), pulse rate, respiratory rate, Glasgow
Coma Scale (GCS), intubation (yes or no), hemoglobin in
g/dl, and imaging data. Splenic injury was diagnosed or
confirmed by i.v. contrast-enhanced Computed Tomogra-
phy (CT) scanning. The Organ Injury Scale of the American
Association for the Surgery of Trauma (AAST) was used to
grade splenic injury [17]. A contrast blush was defined as a
well-circumscribed, peri-splenic or intraparenchymal con-
trast collection that was hyperdense with respect to the rest
of the splenic parenchyma. The values that were used for
SBP are the first values measured upon arrival at the
emergency department. For transferred patients, the values
(if known) and treatment strategy (if performed) in the
hospital of initial assessment were described.
Statistical analysis
Propensity scoringmatching (PSM) is amethodology that can
be used to adjust for treatment selection bias intrinsic to any
observational study to simulate a randomization process as
closely as possible [15]. In propensity score methods, balance
on covariates (or confounders) is achieved through matching.
Matching is based on the estimated chance of receiving the
treatment or simply the propensity score (see Box 1 for more
information about propensity score methods) [18].
Within each group of our study (observation and
embolization), the proportion of participants with the
endpoints defined above was calculated. Subsequently, the
propensity score (probability of being treated with SAE
instead of observation) for each of the individual patients
was calculated, based on a multivariable logistic regres-
sion model including age, SBP, grade of splenic injury
(grade 1–5 according to the AAST grading system), the
presence of contrast extravasation on i.v. contrast-en-
hanced CT scanning, and ISS. The variables that were
included in the logistic regression model had been iden-
tified in a previous systematic review [19]. The scale of
the continuous variables was checked using fractional
polynomials [20]. Subsequently, five strata were created
based on the quintiles of the propensity score distribution
in the cohort. Within each of the five strata, the relative
risk (RR) was calculated. Across strata, a weighted rela-
tive risk was then calculated to express the chances of the
respective endpoint with SAE compared to observation.
Because the secondary endpoint of transfused blood
products is a continuous variable, a linear regression
model was built and covariate adjustment using the
propensity score was performed to calculate the mean
number of transfused blood products, conditional on the
propensity score.
Data analysis was performed using IBM SPSS soft-
ware package version 20 (Inc., Chicago, IL, USA), STATA
version 11 (StataCorp. 2009. Stata Statistical Software:
Release 11. College Station, TX: StataCorp LP), and SAS
version 9.2. Relative risks and weighted relative risks were
reported with their 95 % confidence interval. Categorical
data are expressed as number (percentage) and continuous
data as mean with standard deviation (SD) or median with
interquartile ranges.
Box 1. Propensity score methods
• Propensity score methods are used to adjust  for confounding in observational 
research. 
• The propensity score is the chance to receive the treatment, based on measured 
covariates (or confounders), and is a number between 0 and 1. 
• Propensity scores of (individual) patients are calculated with a regression model. 
• Patients who received the treatment are then compared (or matched) to patients who 
did not receive the treatment, with the same propensity score or patients in the same 
stratum, depending on the matching technique applied. 
• Different methods for matching exist: matching (1 to 1 or 1 to k), stratification (the 
method applied in the present study), inversed probability weighting, and covariate 
adjustment.  
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Results
Patients
Two hundred forty-seven patients were eligible for inclu-
sion. Ten patients had to be excluded because they died of
their injuries shortly after admittance to the Emergency
Department. Twelve patients were excluded because the
splenic injury was incorrectly coded as such or was not
diagnosed before an emergency laparotomy. Nineteen
other patients had to be excluded because they had been
transferred from another hospital, and insufficient infor-
mation was available about initial assessment and clinical
course.
The study cohort consisted of 206 patients. Propensity
scores ranged between 0.001 and 1.00. In three patients, the
propensity score could not be calculated because, instead of
a CT-scan with intravenous contrast, other imaging
modalities had been performed (e.g., FAST). The partici-
pants were divided into five different strata with the fol-
lowing cut-offs for propensity scores: 0.007, 0.023, 0.126,
and 0.75. Stratum 1 contains the patients with the highest
Table 1 Baseline characteristics of observed and embolized patients
per stratum
Observation (n = 149) SAE (n = 57)
Age (years)
Stratum 1 38 (25–45) 46 (32–59)
Stratum 2 42 (23–60) 30 (21–48)
Stratum 3 26 (19–40) 24 (21–42)
Stratum 4 47 (29–62) –
Stratum 5 25 (19–41) –
ISS (points)
Stratum 1 33 (19–36) 33 (22–50)
Stratum 2 23 (14–39) 22 (16–29)
Stratum 3 21 (15–32) 26 (11–37)
Stratum 4 29 (20–35) –
Stratum 5 20 (13–29) –
SBP (RTS categories)*
Stratum 1
50–75 0 (0) 4 (11)
76–89 0 (0) 2 (6)
[89 5 (100) 29 (83)
Stratum 2
76–89 2 (9) 2 (11)
[89 21 (91) 16 (89)
Stratum 3
76–89 2 (5) 0 (0)
[89 35 (95) 4 (100)
Stratum 4
76–89 1 (2) –
[89 40 (98) –
Stratum 5
[89 40 (100) –
Contrast extravasation
Stratum 1
Yes 5 (100) 33 (94)
No 0 (0) 2 (3)
Stratum 2
Yes 15 (65) 17 (94)
No 8 (35) 1 (6)
Stratum 3
Yes 1 (3) 0 (0)
No 36 (97) 4 (100)
Stratum 4
Yes 0 (0) –
No 41 (100) –
Stratum 5
Yes 0 (0) –
No 40 (100) –
Grade of splenic injury
Stratum 1
Grade 1 – 1 (3)
Grade 3 1 (20) 11 (31)
Table 1 continued
Observation (n = 149) SAE (n = 57)
Grade 4 4 (80) 20 (57)
Grade 5 0 (0) 3 (9)
Stratum 2
Grade 1 4 (17) 2 (11)
Grade 2 6 (26) 4 (22)
Grade 3 9 (39) 8 (44)
Grade 4 4 (17) 4 (22)
Stratum 3
Grade 1 2 (5) 0 (0)
Grade 2 4 (11) 0 (0)
Grade 3 25 (68) 2 (50)
Grade 4 6 (16) 2 (50)
Stratum 4
Grade 1 15 (37) –
Grade 2 26 (63) –
Stratum 5
Grade 1 37(93) –
Grade 2 3 (8) –
Data are expressed as number (percentage) or median (interquartile
range)
Patients with the highest propensity score are located in stratum 1 and
patients with the lowest propensity score in stratum 5
ISS injury severity score, SAE splenic artery embolization, SBP sys-
tolic blood pressure
* Class I: 1–49, Class II: 50–75, Class III: 76–89, Class IV:
[89 mmHg
World J Surg (2016) 40:1264–1271 1267
123
propensity score (highest chance of receiving embolization
based on the clinical parameters age, SBP, grade of splenic
injury, the presence of contrast extravasation, and ISS) and
stratum 5 the patients with the lowest propensity score.
Table 1 displays baseline characteristics per stratum. The
five groups of patients were balanced in terms of the
variables used to calculate the propensity score, suggesting
that the propensity stratification was adequate. The type of
embolization was proximal in 36 of the 57 patients (63 %)
and distal in 21 patients (37 %). In one patient, the contrast
extravasation detected on the CT-scan could not be
visualized during angiography, and the interventional
radiologist refrained from embolization.
A total of 14 patients died. Eight patients died due to
traumatic brain injury, 4 patients died of persistent blood
loss and uncontrollable hypotension because of shock in
combination with multi-organ failure, one patient died after
dislocation of the endovascular prosthesis of the superior
mesenteric artery (SMA) following a traumatic aorta and
SMA dissection, and one patient died on the IC unit after
cardiopulmonary resuscitation (cardiogenic shock).
Successful treatment
NOM was successful in 180 patients; in 134 (92 %) of the
observed patients and in 48 (84 %) of the patients with
SAE (Table 2). All embolized patients were in stratum 1, 2,
or 3. After adjusting for age, grade of splenic injury, the
presence of contrast extravasation, SBP, and ISS with
propensity score stratification, there was no significant
difference between the observed and the embolized
patients in terms of successful treatment (weighted RR of
1.17 (0.94–1.45)). Table 2 depicts the RR per stratum.
Initial treatment failed in 24 patients (12 %) (Fig. 1). In
total, five patients (2 %) were readmitted to hospital, of
which one required a re-intervention. Two patients were
treated with percutaneous drainage of a fluid collection
surrounding the spleen (complication).
Observaon
n=149 (72%)
Failure of inial
treatment
n=15 (10%)
Angiography and SAE
n=9
Succesful treatment
n=48 (84%)
Succesful treatment
n=134 (90%)
Embolizaon
n=57 (28%)
Operave treatment
n=6
splenectomy - n=5
SPOM*- n=1
Failure of inial
treatment
n=9 (16%) 
Angiography without 
SAE
n=1
Re-SAE
n=2
Operave treatment
n=6
splenectomy - n=5
emergency 
laparotomy without 
splenectomy‡ - n=1
Fig. 1 Failure of initial treatment and the type of re-interventions
Table 2 Successful treatment within the five strata
PS stratum Observation n (%) SAE n (%) Relative risk
Stratum 1 3/5 (60) 28/35 (80) 1.33 (0.64–2.78)
Stratum 2 18/23 (78) 16/18 (89) 1.14 (0. 87–1.49)
Stratum 3 33/37 (89) 4/4 (100) 1.12 (1.00–1.25)
Stratum 4 40/41 (98) – –
Stratum 5 40/40 (100) – –
Overall 134/146* (92) 48/57 (84) 1.17 (0.94–1.45)
Patients with the highest propensity score are located in stratum 1 and
patients with the lowest propensity score in stratum 5
SAE splenic artery embolization
* In three of the 149 patients, the propensity score could not be
calculated; it was unknown whether a contrast extravasation was
present
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Complications and transfused blood products
A total of 140 complications occurred in 89 patients.
Table 3 displays the complications during index admission
within the five strata. The overall weighted RR was 0.71
(0.41–1.22).
The most frequent complications were pulmonary-re-
lated (e.g., pneumonia or chest tube placement for pleural
fluid (33/138; 23 %)). The second most frequently occur-
ring complication was rebleeding (21/138; 15 %). All but
one of the rebleeds were related to the splenic injury. In 32
(23 %) patients, spleen-related complications occurred.
These included additional abdominal imaging because of
suspected spleen-related clinical deterioration of the patient
(n = 8), the development of a subphrenic abscess after
splenectomy (n = 1), splenic pseudoaneurysm (n= 1),
puncture site pseudoaneurysm (n = 1), and chronic cough
after coiling (n = 1).
There was a trend toward a higher transfusion require-
ment for the embolized patients in the second stratum
(Table 4), but overall there was no significant difference
with regard to the total number of transfused blood prod-
ucts [mean of 4.4 (SD 9.9) in the observed vs. 9.1 (SD
17.2) in the embolized patients; p value 0.75].
Discussion
After correction for confounders with a propensity score
stratification technique, there was no significant difference
between SAE and observation alone with regard to suc-
cessful treatment, all-cause complications, and transfusion
requirements of patients with blunt splenic injury after
trauma. The overall success rates for observation alone and
SAE were 92 and 84 %, respectively.
To our knowledge, this is the first study comparing the
successful treatment rate of SAE to that of observational
management in contemporaneous patients. Observational
management and SAE are very different non-operative
management (NOM) modalities, and important information
may be lost when the two modalities are studied together
[14]. In particular, when the outcomes of patients treated
with observational management and SAE are combined in
NOM studies, the effectiveness of SAE may be masked.
Harbrecht et al. state that the increasing use of CT scanning
has resulted in an increase in the diagnosis of splenic
injuries, and conclude that the proportionally greater
numbers of moderately severely injured patients (ICD-9-
CM 865.02) have also contributed to improved success
rates of NOM over time [12]. However, although not sig-
nificant, our results suggest (point estimates [1, in the
advantage of embolisation) that the improvement in suc-
cess might be attributed to the use of SAE.
All embolized patients were situated in stratums 1–3,
leaving stratum 4 and 5 (lowest probability of undergoing
SAE) empty. This is not surprising, as in daily practice,
Table 3 Complications during index admission within the five strata
PS stratum Observation n (%) SAE n (%) Relative risk
Stratum 1 3/5 (60) 17/35 (49) 0.81 (0.37–1.79)
Stratum 2 12/23 (52) 8/18 (44) 0.86 (0.45–1.63)
Stratum 3 15/37 (41) 0/4 (0) 0 (0–1.70)
Stratum 4 23/41 (56) – –
Stratum 5 10/40 (25) – –
Overall 63/146* (43) 25/57 (44) 0.71 (0.41–1.22)
Patients with the highest propensity score are located in stratum 1 and
patients with the lowest propensity score in stratum 5
SAE splenic artery embolization
* In three of the 149 patients, the propensity score could not be
calculated; it was unknown whether contrast extravasation was
present
Table 4 Mean number of transfused units of blood products within the five strata
PS stratum Observation mean (SD) SAE mean (SD) P value
Stratum 1 1.2 (1.3) 9.8 (18.9) 0.32*
Stratum 2 1.5 (3.1) 9.2 (15.4) 0.053*
Stratum 3 3.0 (5.7) 1.8 (2.1) 0.68*
Stratum 4 7.1 (13.8) – –
Stratum 5 3.2 (7.6) – –
Overall (conditional on the Ps) 4.4 (9.9) 9.1 (17.2) 0.75
Data are presented as mean (SD)
Patients with the highest propensity score are located in stratum 1 and patients with the lowest propensity score in stratum 5
SAE splenic artery embolization
* Independent T test
 P value was calculated with a linear model and covariate adjustment using the propensity score
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embolization is reserved for patients with higher splenic
injury grade, the presence of a contrast extravasation, etc.
The propensity score stratification technique allowed us to
create ‘comparable strata,’ based on the risk factors for
failure of observation identified in the literature, and to
calculate the relative risk for success, complications, and
transfusion requirement with SAE compared to observation
within these strata. With the small overall differences in
successful treatment rates for observation and emboliza-
tion, and the lack of well-defined criteria for embolization
(e.g., where to place the cut-off with regard to size of the
blush), this propensity score matching analysis is an ade-
quate method for analyzing the data. In addition, a
propensity score matching analysis is a good alternative in
a field where it is unimaginable that an RCT will be per-
formed since embolisation has become an established
treatment in the care for patients with splenic trauma.
In the literature, NOM is often declared to be successful
if the spleen is salvaged. We used a combined endpoint
(splenic salvage without re-intervention) because, with the
increasing use of non-operative management, we found
splenic salvage alone to be too crude a measure. Although
splenic salvage is the most important outcome considering
the lifelong risk of severe infection, differences exists
between splenic salvage achieved after initial treatment and
splenic salvage in which several re-interventions were
necessary (from a patient-related point of view, due to use
of resources and length of hospital stay). Therefore, we
included re-interventions in the definition of failure of
treatment.
The failure rate of NOM in our study is comparable to
failure rates cited in the literature [9, 13, 21, 22] and the
percentage of patients undergoing a re-intervention was
equivalent in the NOM group (11 %) and the SAE group
(16 %). While the majority of the patients in whom NOM
failed underwent another non-operative attempt (SAE), two
thirds of the embolized patients in whom treatment failed
underwent operative management. This finding might
support a more liberal (first) attempt with observation.
However, it should be noted that patients with active
bleeding who are hemodynamically compromised are not
eligible for observation and should always undergo an
intervention (six patients in our cohort).
The largest controversy regarding the optimal treatment
strategy seems to be located in stratum 2, since the number
of observed and embolized patients in this stratum is well-
balanced. Further work, preferably with a prospective study
design, needs to be done in this specific patient group to
establish the best treatment modality.
A number of limitations of this study have to be con-
sidered. First, the presence of a contrast extravasation is
thought to be one of the most important indications for
embolization [6, 23–25]. This concept has recently been
challenged by both Thompson and Michailidou et al., who
demonstrated that a contrast blush is not an absolute indi-
cation for an operative or angiographic intervention, but
that it is the size of the blush that matters. Thompson et al.
identified a size of[1 cm as an important element pre-
dicting the need for intervention [26], while Michailidou
et al. defined a cut-off value of 1.5 cm or greater diameter
[27]. However, we did not assess the location of the con-
trast extravasation (intraparenchymal or contained vs.
intraperitoneal or free) or the size of the contrast extrava-
sation. This is a limitation, as it might be that large blushes
are overrepresented in one group, thereby possibly intro-
ducing bias. Although it was standard policy to perform
SAE in the presence of a contrast extravasation, the
majority of the hospitals recruiting patients to the study do
not employ a strict protocol. Differing protocols might
have introduced bias for which we did not correct with the
propensity analysis and this might have weakened the
validity of the study. Another limitation, intrinsic to the
propensity analysis, is that we could not control for
unmeasured confounders. Recently, published studies
conclude that SAE improves the success rate of NOM for
grade 4 and 5 injuries [14, 28, 29]. Although we had a
significant number of patients with grade 4 splenic injury,
only 3 patients suffered from grade 5 injury. The validity of
the results is therefore limited in this patient group. Lastly,
the present study was limited by the relatively low sample
size and specifically the low number of patients in the
different treatment groups in some strata (e.g., number of
observed patients in stratum 1). The fact that the advantage
of embolisation over observation could not be expressed in
a statistically significant difference may be explained by
the relatively small size and the associated lack of power.
Future research with larger patient cohorts, for example, by
means of (international) research cooperation and data
sharing (e.g., individual patient data) will provide a more
definitive answer.
Conclusion
After correction for confounders with propensity score
stratification technique, there was no significant difference
between embolization and observation alone with regard to
successful treatment in patients with blunt splenic injury
after trauma.
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